These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 36233479)
1. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit. Deharo F; Carvelli J; Cautela J; Garcia M; Sarles C; Maues de Paula A; Bourenne J; Gainnier M; Bichon A J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233479 [TBL] [Abstract][Full Text] [Related]
2. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature. Boutros A; Bottini A; Rossi G; Tanda ET; Spagnolo F; Barletta G; Croce E; Fava P; Parisi A; De Rosa F; Palla M; Marconcini R; Ferrari M; Grandis M; Spallarossa P; Sarocchi M; Arboscello E; Del Mastro L; Lambertini M; Pronzato P; Genova C ESMO Open; 2023 Feb; 8(1):100791. PubMed ID: 36791639 [TBL] [Abstract][Full Text] [Related]
3. Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma. Xing Q; Zhang ZW; Lin QH; Shen LH; Wang PM; Zhang S; Fan M; Zhu B Ann Transl Med; 2020 Mar; 8(5):250. PubMed ID: 32309397 [TBL] [Abstract][Full Text] [Related]
4. [Clinical Features of Myasthenia Gravis as an Immune-related Adverse Event]. Suzuki S Brain Nerve; 2024 Jan; 76(1):27-32. PubMed ID: 38191136 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature. Reynolds KL; Guidon AC Oncologist; 2019 Apr; 24(4):435-443. PubMed ID: 30482825 [TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings-A Case Report and Literature Review. Giovannini E; Bonasoni MP; D'Aleo M; Tamagnini I; Tudini M; Fais P; Pelotti S Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446095 [TBL] [Abstract][Full Text] [Related]
11. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil. Jespersen MS; Fanø S; Stenør C; Møller AK Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082 [TBL] [Abstract][Full Text] [Related]
12. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer]. Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386 [TBL] [Abstract][Full Text] [Related]
14. Novel uses of complement inhibitors in myasthenia gravis-Two case reports. Zadeh S; Price H; Drews R; Bouffard MA; Young LH; Narayanaswami P Muscle Nerve; 2024 Mar; 69(3):368-372. PubMed ID: 38205840 [TBL] [Abstract][Full Text] [Related]
15. Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series. Weaver JM; Dodd K; Knight T; Chaudhri M; Khera R; Lilleker JB; Roberts M; Lorigan P; Cooksley T Support Care Cancer; 2023 Aug; 31(9):518. PubMed ID: 37572133 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System. Niimura T; Zamami Y; Miyata K; Mikami T; Asada M; Fukushima K; Yoshino M; Mitsuboshi S; Okada N; Hamano H; Sakurada T; Matsuoka-Ando R; Aizawa F; Yagi K; Goda M; Chuma M; Koyama T; Izawa-Ishizawa Y; Yanagawa H; Fujino H; Yamanishi Y; Ishizawa K J Clin Pharmacol; 2023 Apr; 63(4):473-479. PubMed ID: 36453166 [TBL] [Abstract][Full Text] [Related]
17. Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea. Hyun JW; Kim KH; Kim SH; Kim HJ J Cancer Res Clin Oncol; 2023 Aug; 149(9):5583-5589. PubMed ID: 36495331 [TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases. Pathak R; Katel A; Massarelli E; Villaflor VM; Sun V; Salgia R Oncologist; 2021 Dec; 26(12):1052-1061. PubMed ID: 34378270 [TBL] [Abstract][Full Text] [Related]
19. Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature. Cuenca JA; Hanmandlu A; Wegner R; Botdorf J; Tummala S; Iliescu CA; Nates JL; Reddy DR BMC Anesthesiol; 2023 Sep; 23(1):310. PubMed ID: 37700240 [TBL] [Abstract][Full Text] [Related]